Skip to main content

Table 2 Validation of a cutoff value of 2.6937 for the neutrophil to lymphocyte ratio in predicting serious clinical outcomes for patients with COVID-19

From: Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study

Serious clinical outcomes No. of patients % (95% confidence interval)
Sensitivity Specificity Positive predictive value Negative predictive value
Deterioration 341 82.0 (69.0–91.0) 69.1 (63.8–74.8) 31.3 (23.4–39.7) 95.7 (93.0–99.2)
Shock 338 93.3 (68.0–100) 64.1 (58.9–69.7) 10.8 (5.4–16.3) 99.5 (98.6–100)
Death 341 92.9 (66.0–100) 63.9 (58.7–69.5) 9.9 (4.8–15.2) 99.5 (98.6–100)
\